Identification and Characterization of Novel CFTR Potentiators

There is still a high unmet need for the treatment of most patients with cystic fibrosis (CF). The identification and development of new Cystic Fibrosis Transmembrane conductance Regulator (CFTR) modulators is necessary to achieve higher clinical benefit in patients. In this report we describe the c...

Descripción completa

Detalles Bibliográficos
Autores principales: Gees, Maarten, Musch, Sara, Van der Plas, Steven, Wesse, Anne-Sophie, Vandevelde, Ann, Verdonck, Katleen, Mammoliti, Oscar, Hwang, Tzyh-Chang, Sonck, Kathleen, Stouten, Pieter, Swensen, Andrew M., Jans, Mia, Van der Schueren, Jan, Nelles, Luc, Andrews, Martin, Conrath, Katja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212544/
https://www.ncbi.nlm.nih.gov/pubmed/30416447
http://dx.doi.org/10.3389/fphar.2018.01221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212544/
https://www.ncbi.nlm.nih.gov/pubmed/30416447
http://dx.doi.org/10.3389/fphar.2018.01221

Ejemplares similares